A phase II study of SCH 54031 (peg interferon alpha-2b/PEG-intron) in subjects with interferon-refractory chronic myelogenous leukemia
Phase of Trial: Phase II
Latest Information Update: 13 Nov 2018
At a glance
- Drugs Peginterferon alfa-2b (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 07 Jul 2009 Planned patient numbers changed from 30 to 1 as reported by ClinicalTrials.gov.
- 21 Jul 2006 New trial record.